Creative Biolabs-Immuno-oncology

Anti-CLEC12A (clone 2E1GC9Q.L2EH3) SynExpress T7-mCh-cJ-K Modified CD8+ T cells (CAT#: ITS-1224-CR1938)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CLEC12A (clone 2E1GC9Q.L2EH3). We employs the AAV (T7-mCherry-c-Jun-KpnI) vector components and the SynExpress system of the Coding regions Deletion/Negative feedback for a robust and sustained response against cancers.
Host
Human
Target
CLEC12A
Clone
2E1GC9Q.L2EH3
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
mCherry
Promoter
T7
Effector Gene
c-Jun
Insertion Sites
KpnI
Gene Modification
Deletion
Modification Domain
Coding regions
Carrier Type
AAV
Transformation Accuracy
0.86
Cell Culture
Suspension Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving